20/14221: Motion for the Federal Government to Cease Disseminating Advertising-Style Information on Puberty Blockers and Hormone Treatment for Children and Adolescents
On December 16, 2024, a motion (20/14221) was submitted to the German Bundestag calling for the federal government to stop disseminating promotional information about puberty blockers and hormone treatment for children and adolescents. The motion was submitted by the Alternative for Germany (AfD) parliamentary group.
Background
The motion arose amid concerns about the potential risks and side effects of puberty blockers and hormone treatment for young people. Puberty blockers and hormone treatments are medical interventions used to delay or suppress puberty in transgender and gender-diverse youth.
Motion Arguments
The motion argues that the government should not be providing promotional information about these interventions, as it could influence young people to make decisions that may have long-term consequences for their health and well-being.
The motion also expresses concern that the government’s dissemination of such information could be interpreted as an endorsement of puberty blockers and hormone treatment, which the motion argues is inappropriate given the ongoing scientific debate about their potential risks and benefits.
Proposed Measures
The motion proposes that the government take the following measures:
- Cease all dissemination of promotional information about puberty blockers and hormone treatment for children and adolescents.
- Provide balanced and objective information about these interventions, including information about their potential risks and benefits.
- Ensure that young people have access to independent and unbiased information before making decisions about puberty blockers or hormone treatment.
Current Status
As of January 2023, the motion is still under consideration by the Bundestag. The Committee on Health has been assigned to review the motion and make a recommendation to the Bundestag.
Significance
This motion is significant because it raises important questions about the role of the government in providing information about medical interventions for young people. It also highlights the ongoing debate about the potential risks and benefits of puberty blockers and hormone treatment for transgender and gender-diverse youth.
The AI has provided us with the news.
I’ve asked Google Gemini the following question, and here’s its response.
Drucksachen a new article on 2024-12-16 11:00 titled “20/14221: Antrag Unterlassung von Informationen mit bewerbendem Charakter zu Pubertätsblocker- und Hormonbehandlung von Kindern und Jugendlichen seitens der Bundesregierung (PDF)”. Please write a detailed article on this news item, including any relevant information. Answers should be in English.
66